AIMS/HYPOTHESIS: Islet cell death is a key initiating and perpetuating event in type 1 diabetes and involves both immune-mediated and endogenous mechanisms. The epithelial pantetheinase vanin-1 is proinflammatory and cytoprotective via cysteamine release in some tissues. We investigated the impact of a vanin-1 deficiency on islet death and type 1 diabetes incidence. METHODS: Vanin-1-deficient mice were produced and tested in drug-induced and autoimmune diabetes models. The contribution of vanin-1 to islet survival versus immune responses was evaluated using lymphocyte transfer and islet culture experiments. RESULTS: The vanin-1/cysteamine pathway contributes to the protection of islet beta cells from streptozotocin-induced death in vitro and in vivo. Furthermore, vanin-1-deficient NOD mice showed a significant aggravation of diabetes, which depended upon loss of vanin-1 expression by host tissues. This increased islet fragility was accompanied by greater CD4+ insulitis without impairment of regulatory cells. Addition of cystamine, the product of pantetheinase activity, protected islets in vitro and compensated for vanin-1 deficiency in vivo. CONCLUSIONS/ INTERPRETATION: This study unravels a major cytoprotective role of cysteamine for islet cells and suggests that modulation of pantetheinase activity may offer alternative strategies to maintain islet cell homeostasis.
AIMS/HYPOTHESIS: Islet cell death is a key initiating and perpetuating event in type 1 diabetes and involves both immune-mediated and endogenous mechanisms. The epithelial pantetheinasevanin-1 is proinflammatory and cytoprotective via cysteamine release in some tissues. We investigated the impact of a vanin-1 deficiency on islet death and type 1 diabetes incidence. METHODS:Vanin-1-deficient mice were produced and tested in drug-induced and autoimmune diabetes models. The contribution of vanin-1 to islet survival versus immune responses was evaluated using lymphocyte transfer and islet culture experiments. RESULTS: The vanin-1/cysteamine pathway contributes to the protection of islet beta cells from streptozotocin-induced death in vitro and in vivo. Furthermore, vanin-1-deficient NOD mice showed a significant aggravation of diabetes, which depended upon loss of vanin-1 expression by host tissues. This increased islet fragility was accompanied by greater CD4+ insulitis without impairment of regulatory cells. Addition of cystamine, the product of pantetheinase activity, protected islets in vitro and compensated for vanin-1 deficiency in vivo. CONCLUSIONS/ INTERPRETATION: This study unravels a major cytoprotective role of cysteamine for islet cells and suggests that modulation of pantetheinase activity may offer alternative strategies to maintain islet cell homeostasis.
Authors: Lisl K M Shoda; Daniel L Young; Saroja Ramanujan; Chan C Whiting; Mark A Atkinson; Jeffrey A Bluestone; George S Eisenbarth; Diane Mathis; Aldo A Rossini; Scott E Campbell; Richard Kahn; Huub T C Kreuwel Journal: Immunity Date: 2005-08 Impact factor: 31.745
Authors: Kathryn Haskins; Brenda Bradley; Katherine Powers; Valerie Fadok; Sonia Flores; Xiaofeng Ling; Subbiah Pugazhenthi; Jane Reusch; Jennifer Kench Journal: Ann N Y Acad Sci Date: 2003-11 Impact factor: 5.691
Authors: Belinda J Kaskow; J Michael Proffitt; J Michael Proffit; John Blangero; Eric K Moses; Lawrence J Abraham Journal: Biochem Biophys Res Commun Date: 2011-12-01 Impact factor: 3.575
Authors: John T Pinto; Tetyana Khomenko; Sandor Szabo; Gordon D McLaren; Travis T Denton; Boris F Krasnikov; Thomas M Jeitner; Arthur J L Cooper Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2009-05-28 Impact factor: 3.205
Authors: Janna A van Diepen; Patrick A Jansen; Dov B Ballak; Anneke Hijmans; Floris P J T Rutjes; Cees J Tack; Mihai G Netea; Joost Schalkwijk; Rinke Stienstra Journal: Sci Rep Date: 2016-03-02 Impact factor: 4.379